Skin sterol study
This article was originally published in The Tan Sheet
Executive Summary
People with high levels of skin tissue cholesterol and C-reactive protein have nearly double the risk of metabolic syndrome compared to those without elevated levels of both markers, according to data presented by PreMD at the American Heart Association's Annual Arteriosclerosis, Thrombosis & Vascular Biology conference in Toronto April 27. The study used PREVU* Point Of Care Skin Sterol Test to measure skin sterol and C-reactive protein levels in 301 patients with established coronary artery disease to assess whether the two markers could help predict metabolic syndrome. "The prevalence of metabolic syndrome in was significantly higher in patients who scored highest for both skin sterol and C-reactive protein, and remained significant after adjustment for age and gender, compared to isolated elevators of either marker alone," Milan Gupta, MD, McMaster University, Ontario, et al., state. PreMD is currently investigating a home-use version of the PREVU* test, which is currently designed for use by medical professionals. However, the home-use product has not yet entered the clinical stage, a spokesperson says...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.